Inhibiting the acetyltransferase activity of KAT8 could suppress the repair of elevated DNA damage in tumor cells, offering a strategy for developing chemotherapeutic agents or adjuvant therapies for radiotherapy/chemotherapy. This evidence concerns the gene KAT8 and neoplasm.